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Introduction

44
Replicon-based plasmids derived from Herpesviruses (e.g. Epstein-Barr virus), 45
Polyomaviruses (e.g. BK virus, Simian virus 40), Papillomaviruses (e.g. bovine papilloma 46 virus 1), or Geminiviruses (e.g. bean yellow dwarf virus) have been developed recently for 47 gene expression and gene therapy (Kim et al., 2006; Mor et al., 2003; Shibata et al., 2005; 48 Van Craenenbroeck et al., 2000b). These plasmids contain a viral origin of replication and the 49 viral genes necessary for replication. Replicon-based plasmids have proved to be highly 50 valuable tools for: (1) producing high levels of proteins of interest in plants (Hefferon and 51 Fan, 2004; Mor et al., 2003) ; (2) delivering of therapeutic or complementing gene products 52 (Kim et al., 2006) ; (3) studying the regulation of replication (Takeda et al., 2005) ; and (4), 53 potentially, enhancing immune responses induced by DNA-based vaccines. 54
The porcine circovirus type 2 (PCV2), a member of the genus Circovirus, family 55
Circoviridae, contains a circular, single-stranded, positive-sense DNA genome which is about 56 1.8 kb in size. The intergenic region containing the origin of replication has a stem-loop 57 structure, which includes an octanucleotide sequence flanked by palindromes, and is bordered 58 by two open reading frames, ORF1 and ORF2. ORF1 is located on the positive strand and 59 encodes the Rep and Rep' proteins involved in replication initiation. ORF2 is located on the 60 negative strand of the intermediate double-stranded PCV2 genome that forms during 61 replication and it encodes the Cap protein, the capsid protein in PCV2 (Mankertz et al., 2004) . 62
Owing to their ability to produce high levels of proteins in a short time, PCV2-based plasmids 63 may be valuable vectors for vaccine purposes compared to latent virus-based plasmids. 64 DNA replication of replicon-based plasmids in eukaryotic cells can be measured. The 65 replicated plasmid molecules can be distinguished from the initially transfected, input plasmid 66 molecules by their resistance to the DpnI restriction enzyme, which can only cleave DNA that 67 has been dam-methylated in bacteria. Thus, replicated plasmids can be detected by Southern 68 blotting (Mankertz et al., 1997) or by quantitative PCR (qPCR) (Baxter and McBride, 2005; 69 Taylor and Morgan, 2003) . In comparison with Southern blotting, quantitative PCR is a 70 highly sensitive and quantitative method for detecting DNA replication and is significantly 71 faster (Taylor and Morgan, 2003) . 72
For DNA-vaccine purposes, it is important to use a replicon-based plasmida so-called 73 replicative plasmidthat replicates rapidly to produce high quantities of vaccinating 74 proteins in a short time. However, little is known about the replication efficiency of 75 replicative plasmids. Replication efficiency can be estimated by comparing replicated 76 plasmids to the total number of extracted plasmids. In plasmids that undergo theta replication, 77 replication efficiency has been measured by comparing the number of plasmids after 78 incubation with and without DpnI (Takeda et al., 2005) . 79
The difference between rolling-circle replication and theta replication is that rolling-circle 80 replicons replicate via a nicked-DNA intermediate and produce single-stranded DNA (Faurez 81 et al., 2009) . The aim of the present study was to characterise a method to estimate the 82 efficiency of DNA replication of different rolling-circle, replicon-based plasmids using qPCR. 83
This information will be used to determine the replication rates of replicating plasmids and to 84 evaluate whether different primer pairs or different quantitative PCR protocols influence the 85 estimation of replication rates. PCV2 replicon-based plasmids were used as the rolling-circle 86 model. 87 88 2. Materials and methods 89
Culture of PK15 cells 90
Porcine circovirus type 1 (PCV1)-free porcine kidney (PK15) cells were grown in Eagle 91 minimal essential medium supplemented with 5% foetal bovine serum and 1% penicillin 92 (10 000 u/mL)-streptomycin (10 000 µg/mL) (Gibco, Invitrogen, Carlsbad, CA, USA) in 5% 93 CO 2 at 37°C and split 1:10 twice a week. 94 95
Replicative and non-replicative plasmid constructs 96
The pcDNA3 plasmid and the cloning vectors pCR4 and pBlueScript KS+ were obtained 97 from Invitrogen (Carlsbad, CA, USA). Five fragments were inserted into the plasmids ( Figure  98 1a): (1) the enhanced green fluorescent protein (eGFP) reporter gene (GenBank accession no. 99
U57609.1);
(2) the porcine circovirus type 2 (PCV2) OriRep fragment (GenBank accession 100 no. AF201311) that contains the Rep promoter, the origin of replication and ORF1 (Fig. 2) ; 101
(3) the cytomegalovirus immediate-early promoter (pCMV) of pcDNA3; (4) a PCR amplicon 102 obtained with oGVB2115 primers (Table 1) In all, eleven plasmids were constructed for specific purposes (Fig. 1a ). Two plasmids were 107 constructed to optimise the determination of the replication rate. A non-replicative plasmid 108 was obtained by inserting the pCMV and the eGFP reporter gene into pCR4 (pCR4-GFP). A 109 replicative plasmid was obtained by inserting PCV2 OriRep. The PCV2 OriRep fragment was 110 amplified by PCR from PCV2 (Fenaux et al., 2002) using the oGVB2100 primer pair (Table  111 1) and inserted into pCR4 (pCR4-Orirep). Then, to test the optimised determination method, 112 one non-replicative plasmid and three replicative plasmids were constructed. The non-113 replicative plasmid was obtained by inserting the eGFP gene into pcDNA3 (pcDNA3-GFP). 114
For the replicative plasmids, the OriRep fragment was inserted at three different distances 115 from the CMV promoter in the pcDNA3 plasmid. The PCV2 OriRep fragment was amplified 116 by PCR from PCV2 using the oGVB2101 or the oGVB2106 primer pair (Table 1) and 117 inserted into pCR4. Each OriRep fragment was isolated from the pCR4 backbone by digestion 118 with specific restriction endonucleases, as indicated in Figure 1a 
Transfection of PK15 cells with PCV2-based replicative and non-replicative 152 plasmids 153
Twenty-four hours before transfection, 4.5 × 10 5 of PK15 cells were plated onto 6-well tissue 154 culture plates. The final volume was 2 mL. For the quantitative real-time PCR-based 155 replication assay, 10 ng of plasmids were transfected to optimise the method and 10 9 copies of 156 plasmids were transfected to study the replication of different plasmids. The plasmids were 157 input plasmids (i.e. generated in prokaryotic (bacterial) cells), whereas the GATC site is not 176 methylated in plasmids that replicate in eukaryotic cells. Therefore, to differentiate replicated 177 from non-replicated plasmids, low-molecular-weight DNA extracted from PK15 cells was 178 incubated either with DpnI that cuts the dam-methylated GATC site or with MboI that, on the 179 contrary, cuts the non-methylated GATC site. To reduce the background level that is observed 180 in quantitative real-time PCR due to incompletely digested DNA, Exonuclease III (ExoIII) 181 was added to digest any incompletely cut DNA (Taylor and Morgan, 2003) . ExoIII is an 182 exodeoxyribonuclease that does not act on intact circular plasmids, but rather digests one 183 strand of duplex DNA at a blunt end, at a 5' overhang or at internal nicks. The enzyme acts in 184 a 3' 5' direction and produces stretches of single-stranded DNA (Rogers and Weiss, 1980; 185 Weiss, 1976) . The conditions of digestion used were those described previously (Morgan and 186 Taylor, 2005) . 187
In preliminary experiments, TaqMan and SYBR Green real-time PCR assays were compared. 188
The SYBR Green protocol was used in for the rest of the study. Primer pairs and probes 189 indicated in Table 1 were were considered to be different if the Type I error was less than 5% and considered to be 228 similar if the Type II error was less than 20%, i.e. a power higher greater than 80%, for an 229 associated Type I error at 5% (Jenny, 2001; Melot, 2003) . The Mann-Whitney test was used 230 for comparisons of differences in the results of real-time PCR on two different amplification 231 targets and in the results of real-time PCR using the TaqMan probe or SYBR Green.
Results
233
Optimisation of the replication rate calculation 234
In this study, the replication rate was defined as the percentage of replicated plasmids at 24 h 235 post-transfection. To evaluate the replication rate of plasmids, a quantitative real-time PCR-236 based assay was developed to quantify input plasmids or replicated plasmids, but not the 237 cotransfected pcDNA3.1-Rep replication booster. To do so, the PCR primers targeted a 238 GATC site and this site is not present in pcDNA3.1-Rep. In theory, the quantity of plasmids 239 after incubation with ExoIII (qE) should be equal to the sum of the quantity of plasmids 240 incubated with DpnI and ExoIII and the quantity of plasmids incubated with MboI and ExoIII 241 (qDE+qME). Consequently, the replication rate can be calculated using qE or qDE+qME as 242 the denominator. 243
To test this assumption, the number of plasmid copies of pCR4-GFP and of pCR4-Orirep 244 were quantified. Visually, qE did not appear different from qDE+qME (Fig. 3) . In the case of 245 pCR4-GFP, statistics showed that qE and qDE+qME were not significantly different 246 (p=0.766). However, these two groups were not shown to be similar, because the Type II 247 error was greater than 20%. To conclude on similarity at a Type II error of 20%, quantitative 248 PCR must be performed 1526 times for each type of plasmid. In the case of pCR4-Orirep, 249 statistical tests showed that qE and qDE+qME were significantly different (p=0.017). 250 Therefore, the assumption could not be validated for replicative plasmids. The replication rate 251 of replicative plasmids incubated with MboI and ExoIII exceeded 100% when using qE as the 252 denominator in the calculation (data not shown). qME and qDE had the same conditions of 253 digestion; thus the replication rate was calculated using qDE/(qME+qDE). 254
Detection of Rep and Rep' mRNA production 256
Reverse-transcription PCR was used to analyse the transcription of Rep and Rep' proteins 257 encoded by pOrirep0.2-GFP or by pcDNA3.1-Rep. Reverse-transcription PCR amplified two 258 cDNA fragments corresponding to the Rep mRNA (774pb) and to the spliced mRNA of Rep' 259 (391pb) for pOrirep0.2-GFP and for pcDNA3.1-Rep (Fig. 4) . These bands were not present in 260 the cDNA controls of PK15 cells that were not transfected or that were transfected by non-261 replicative pcDNA3. Thus, the expression of both Rep and Rep' could be detected. 262 tested with pcDNA3-GFP and pOrirep0.2-GFP (Fig. 1a) ; each plasmid was cotransfected with 277 pcDNA3.1-Rep. One primer pair was situated in the neomycin gene with a GATC site located 278 in the middle of the amplicon, and the other primer pair was placed at the junction of the GFP 279 gene and the pcDNA3 backbone with a GATC site located in the reverse primer (Fig. 6a) . 280
Neither the quantity of plasmids evaluated by the formula qDE+qME (Fig. 6b ) nor the Page 13 replication rates (Fig. 6c ) were significantly different, whatever the primer pair. This was 282 verified for pcDNA3-GFP and pOrirep0.2-GFP ( Fig. 6b and 6c) . Moreover, the use of a 283
TaqMan probe or a SYBR Green dye (Fig. 7a ) did not introduce significant variation in the 284 quantity of plasmids measured (Fig. 7b ) or in the mean replication rates (Fig. 7c) replicative plasmids have a mean background replication rate below 5% (Fig. 8 ). pCR4-291
Orirep showed a mean replication rate of 63% ± 8%. The mean replication rates of the three 292 replicative plasmids encoding the eGFP gene were lower, i.e. 14% ± 2%, 13% ± 3% and 12% 293 ± 2% for pOrirep1.2-GFP, pOrirep0.2-GFP and pOrirep3.2-GFP, respectively. Compared to 294 the three replicative eGFP encoding plasmids, pCR4-Orirep was smaller (5.2kb vs. 7.4kb) and 295 did not contain strong eukaryotic promoters such as pCMV and pSV40. 296
Mean replication rate depended on plasmid size, but not on the presence of 297 strong eukaryotic promoters 298
To determine whether the size of the plasmid or the presence of strong eukaryotic promoters 299 could modify the mean replication rates of the PCV2-based replicons, five additional plasmids 300 were constructed and tested. Plasmids with or without eukaryotic promoters and greater than 301 5.9 kb in size still had low mean replication rates. On the contrary, 5.2 kb plasmids with or 302 without eukaryotic promoters had replication rates of about the same magnitude as pCR4-303 Orirep (Fig. 8) . 304 305
Discussion
306
In this study, a rapid, quantitative real-time PCR-based assay was developed to measure the 307 replication rates of PCV2-based replicons. The replication rate was defined as the percentage 308 at 24 h post-transfection of the number of replicated plasmids compared to the total number of 309 plasmids present in the cells (i.e. replicated and initial input plasmids). The choice of the 310 Escherichia coli strain in which replicon-based plasmids were produced was important. For 311 example, the E. coli TOP10 strain has more mutations in the system of methylation and 312 restriction (hsdRMS gene) than the DH5α strain; this difference caused an increase in the 313 replication rate (data not shown). Primers for short PCR amplicons containing a GATC 314 sequence were designed to discriminate between replicated and non-replicated plasmids after 315 incubation in eukaryotic cells. A plasmid encoding the PCV2 Rep protein (pcDNA3.1-Rep) 316 was needed to boost and to detect the in vitro replication of the PCV2-based replicons. 317
Comparable replication rates were determined using two different amplification targets. The 318 use of a specific TaqMan probe and amplicon detection using SYBR Green dye also resulted 319 in comparable replication rates. 320
As in theta replication, rolling-circle replication is a semi-conservative replication system. 321
However, a rolling-circle replicon replicates via a nicked DNA intermediate and produce 322 single-stranded DNA (Faurez et al., 2009 ). The present study showed that the quantity of 323 plasmids after incubation with ExoIII (qE) and the sum of the quantity of plasmids after 324 incubation with DpnI and ExoIII plus the quantity of plasmids after incubation with MboI and 325 ExoIII (qDE+qME) were significantly different in replicative plasmids. This difference may 326 be due to the products of rolling-circle replication, namely single-stranded DNA and nicked 327 DNA. In contrast to viruses that replicate via rolling-circle replication, rolling-circle replicon-328 based plasmids do not encode the capsid protein which up-regulates the amount of single-329 stranded DNA by protecting viral DNA from host proteins (Padidam et al., 1999) . 2000a). The present study showed that size had an impact on the replication rate of rolling-375 circle replicon-based plasmids, since plasmids with a size of around 5.2 kb replicated at a high 376 rate and plasmids with larger sizes replicated at lower rates. Prokaryotic rolling-circle 377 replicons generate high-molecular-weight DNA during replication in prokaryotic cells when a 378 fragment is inserted into the replicon (Dabert et al., 1992; Gruss and Ehrlich, 1988) . It is 379 possible that replication of PCV2 replicon-based plasmids was initiated, but that replication 380 could not be terminated due to the large plasmid size, thereby affecting the replication rate. In 381 this study, the strong eukaryotic promoters pCMV and pSV40 did not affect the replication 382 rates. 383
In conclusion, the method described in this study made it possible to calculate plasmid 384 replication rates in eukaryotic cells and to compare different rolling-circle replicons. Using 385 this method, the influence of plasmid size, the presence of strong eukaryotic promoters and 386 the location of the OriRep sequence in the plasmid were studied. This method should be 387 useful for rolling-circle or theta replicons, and in particular for studying the regulation of 388 replicon or virus replication. The quantitative real-time PCR assay reported here could also 389 advantageously be used to evaluate the replication potential of replicon-based plasmids 390 developed for vaccine purposes. Unlike gene therapy, the replicon-based plasmids have to 391 replicate rapidly to produce large amounts of the encoded proteins of interest in a short time. promoter; black arrow: PCR amplicon obtained with oGVB2115 primers (Table 1) ; white 492 arrow: PCR amplicon obtained with oGVB2117 primers (Table 1) 
